Skip to main content

Shenzhen Salubris Pharmaceuticals

Shenzhen Salubris Pharmaceuticals Co Ltd is a Chinese multinational pharmaceutical and biotechnology enterprise specializing in the research, development, manufacturing, and commercialization of prescription pharmaceutical drugs, innovative biological therapeutics, and cardiovascular medical devices. The company produces advanced cardiovascular medications, anti-thrombotic drugs, orthopedic biological products, and innovative oncology drugs supplied to hospitals, clinics, and medical institutions across China and international markets. Its core business operations encompass pharmaceutical drug manufacturing, clinical trial execution, chemical synthesis, and commercial pharmaceutical distribution. Revenue is derived primarily from the wholesale sale of cardiovascular prescription drugs and biological therapeutic formulations. Shenzhen Salubris Pharmaceuticals holds a leading market position in cardiovascular pharmaceutical manufacturing in China. The company is headquartered in Shenzhen, Guangdong Province, China, and its shares trade on the Shenzhen Stock Exchange.

3 of the funds FundTelligence covers report a position in Shenzhen Salubris Pharmaceuticals.

Legal name
Shenzhen Salubris Pharmaceuticals Co Ltd
Sector
Health Care
Country
China
Funds holding it
3

Funds holding Shenzhen Salubris Pharmaceuticals

Loading...